Page last updated: 2024-10-27

fluorouracil and Proctocolitis

fluorouracil has been researched along with Proctocolitis in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Proctocolitis: Inflammation of the RECTUM and the distal portion of the COLON.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kendal, WS1
Jonker, D1
Stern, H1
Moyana, T1
Sweeney, T1
Rieger, N1
Mackay, J1

Other Studies

2 other studies available for fluorouracil and Proctocolitis

ArticleYear
Acute proctocolitis with commencement of neoadjuvant chemoradiation for rectal cancer.
    American journal of clinical oncology, 2006, Volume: 29, Issue:5

    Topics: Acute Disease; Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Dose Fractionation, Radiation;

2006
Neutropenic proctosigmoiditis complicating breast cancer chemotherapy.
    The Australian and New Zealand journal of surgery, 1999, Volume: 69, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Clostridium Infections;

1999